STOCK MARKET BSE NSE

US: Covid vaccines likely to be available early November for children aged 5 to 11, says Fauci

An advisory panel to the FDA will consider Pfizer's application for those ages 5 to 11 on Tuesday. Children 12 and up have been eligible for vaccination since May.

Published: 25th October 2021 12:09 PM  |   Last Updated: 25th October 2021 12:09 PM   |  A+A-

A syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading. (Photo | AP)

By ANI

WASHINGTON: American children ages 5 to 11 may be eligible for COVID-19 vaccines shot by early next month, said US top coronavirus adviser Dr Anthony Fauci.

According to New York Times, Food and Drug Administration regulators on Friday (local time) released their evaluation of data from the Pfizer-BioNTech submission for emergency authorization of a lower-dose vaccine for young children.

An advisory panel to the FDA will consider Pfizer's application for those ages 5 to 11 on Tuesday. Children 12 and up have been eligible for vaccination since May, the publication reported.

Pfizer's data "look good as to the efficacy and safety," Dr Fauci said, NYT reported citing ABC's news program, "This Week."

Pfizer and BioNTech asked federal regulators on Thursday to authorize emergency use of their coronavirus vaccine for children ages 5 to 11, a move that could help protect more than 28 million people in the United States.

The companies said they are submitting data supporting the change to the Food and Drug Administration. The agency has promised to move quickly on the request and has tentatively scheduled a meeting on October 26 to consider it. An FDA ruling is expected as early as Halloween.

A meeting of expert advisers to the Centers for Disease Control and Prevention has been scheduled for November 2 and 3, according to people familiar with the planning. The CDC's recommendations are typically the federal government's last word on vaccine policy.

"With new cases in children in the US continuing to be at a high level, this submission is an important step in our ongoing effort against COVID-19," Pfizer said on Thursday, according to New York Times.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp